Abstract
Olfactory neuroblastoma (ONB) is a relatively uncommon neoplasm, and its clinicopathological presentation remains unclear. In this study, we investigated the correlation of the clinicopathological presentation with the prognosis of ONB. Twelve ONBs histologically diagnosed during the past 12 years at our university were examined. The tumors were classified in accordance with Kadish clinical staging and Hyams’ histological grading. For immunohistochemical analysis, the antibodies of CXCL12, CXCR4, AE1/AE3, CAM5.2, Ber-EP4, Bcl-2, and MIB-1 were used. The patients ranged in age from 19 to 82 years old, and there were five males and seven females. Eight cases had intracranial tumor progression, which equals the advanced Kadish stage (stage C). According to histological grading, five low-grade (grades 1 and 2) and seven high-grade (grades 3 and 4) cases were included. Regarding the prognosis of ONB, a relationship was demonstrated with Hyams’ grading, without Kadish staging. The MIB-1 labeling indices of Hyams’ high-grade group were increased significantly compared to those of the low-grade group, and the expression level of Bcl-2 was strongly correlated with Hyams’ grading. Neither of the chemokines CXCL12 and CXCR4 played a critical role as a prognostic factor, nor did any of the epithelial markers, AE1/AE3, CAM5.2, and Ber-EP4.
Similar content being viewed by others
References
Berger L, Luc G, Richard D (1924) L’esthesioneuroepitheliome olfactif. Bull Assoc Franc Etude Cancer 13:410–421
Finkelstein SD, Hirose T, VandenBerg SR (2005) Pathology and genetics of head and neck tumors. In: Barnes L (ed) International Agency for Research on Cancer (IARC), Lyon, France, pp 66–70
Dulguerov P, Calcaterra T (1992) Estheioneuroblastoma: the UCLA experience 1970–1990. Laryngoscope 102:843–849
Hyams VJ, Batsakis JG, Michaels L (1988) Tumors of the upper respiratory tract and ear. 2nd series, fascicle 25. In: Hyams VJ (ed) Armed Forces Institute of Pathology, Washington, pp 240–248
Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571–1576
Hassoun J, Gambarelli D, Grisoli F, Henric A, Toga M (1981) Esthesioneuroepithelioma, a true neurosensorial tumor. Light- and electron-microscopic study of a case with endocranial extension. Acta Neuropathol 55:77–80
Takahashi H, Ohara S, Yamada M, Ikuta F, Tanimura K, Honda Y (1987) Esthesioneuroepithelioma: a tumor of true olfactory epithelium origin. An ultrastructural and immunohistochemical study. Acta Neuropathol 75:147–155
Takahashi H (1994) Olfactory neuroblastoma (aesthesioneuroblastoma) and olfactory neuroepithelioma. No To Shinkei 46:1134–1141 (Article in Japanese)
Okabe H, Okubo T, Adachi H, Ishikawa T, Ochi Y (1997) Immunohistochemical demonstration of cytokeratin in human embryonic neurons arising from placodes. Brain Dev 19:347–352
Okabe H, Okubo T, Ochi Y (1997) On the origin and diagnostic criteria of olfactory neuroblastoma. Acta Histochem Cytochem 30:181–188
Utsuki S, Kawano N, Oka H, Shimizu S, Sagiuchi T, Saegusa H, Fujii K, Yagishita S, Okabe H (2000) Olfactory neuroepithelioma arising from the olfactory placode. Clin Neuropathol 19:7–12
Sugita Y, Kusano K, Tokunaga O, Mineta T, Abe M, Harada H, Shigemori M (2006) Olfactory neuroepithelioma: an immunohistochemical and ultrastructural study. Neuropathology 26:400–408
Kim JW, Kong IG, Lee CH, Kim DY, Rhee CS, Min YG, Kim CW, Chung JH (2008) Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngol Head Neck Surg 139:708–712
Diensthuber M, Potinius M, Rodt T, Stan AC, Welkoborsky HJ, Samii M, Schreyogg J, Lenarz T, Stover T (2008) Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma. J Neurooncol 89:131–139
Fulton AM (2009) The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 11:125–131
Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171–179
Morita A, Ebersold MJ, Olsen KD (1993) Esthesinoneuroblastoma: prognosis and management. Neurosurgery 32:706–715
Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC (1979) Esthesioneuroblastoma. Cancer 44:1087–1094
Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC (1994) Esthesioneuroblastoma. Long-term outcome and patterns of failure—the University of Virginia experience. Cancer 73:2556–2562
de Gabory L, Abdulkhaleq HM, Darrouzet V, Bébéar JP, Stoll D (2011) Long-term results of 28 esthesioneuroblastomas managed over 35 years. Head Neck 33:82–86
Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Harner SG, VandenBerg SR (1995) Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 76:4–19
McGrath KE, Koniski AD, Maltby KM, McGann JK, Palis J (1999) Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 213:442–456
Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872–877
Komatani H, Sugita Y, Arakawa F, Ohshima K, Shigemori M (2009) Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 34:665–672
Terasaki M, Sugita Y, Arakawa F, Okada Y, Ohshima K, Shigemori M (2011) CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol 28:89–97
Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q, O’Connor M, Hoxie JA, González-Scarano F (1997) CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 151:1035–1042
Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul CC, Yoshie O, Matsushima K, Yoshida N, Springer TA, Kishimoto T (1996) Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci 93:14726–14729
Miyasaka N, Knaut H, Yoshihara Y (2007) Cxcl12/Cxcr4 chemokine signaling is required for placode assembly and sensory axon pathfinding in the zebrafish olfactory system. Development 134:2459–2468
Banisadr G, Dicou E, Berbar T, Rostene W, Lombet A, Haour F (2000) Characterization and visualization of [125I] stromal cell-derived factor-1α binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol 110:151–160
Mao L, Xia YP, Zhou YN, Dai RL, Yang X, Wang YJ, Duan SJ, Qiao X, Mei YW, Hu B (2009) Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma. Oncology 77:231–243
Bockmuhl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I (2004) CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol 14:158–163
Guled M, Myllykangas S, Frierson HF, Mills SE, Knuutila S, Stelow EB (2008) Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol 21:770–778
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukushima, S., Sugita, Y., Niino, D. et al. Clincopathological analysis of olfactory neuroblastoma. Brain Tumor Pathol 29, 207–215 (2012). https://doi.org/10.1007/s10014-012-0083-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-012-0083-3